D
Inari Medical, Inc.
NARI
NASDAQ
E
Sell
6/12/2023Downgrade
Inari Medical, Inc. (NARI) was downgraded to E+ from D- on 6/12/2023 due to a decline in the volatility index.
Inari Medical, Inc. (NARI) was downgraded to E+ from D- on 6/12/2023 due to a decline in the volatility index.
D
Sell
5/4/2023Downgrade
Inari Medical, Inc. (NARI) was downgraded to D- from D on 5/4/2023 due to a significant decline in the efficiency index, total return index and volatility index.
Inari Medical, Inc. (NARI) was downgraded to D- from D on 5/4/2023 due to a significant decline in the efficiency index, total return index and volatility index.
D
Sell
11/14/2022Downgrade
Inari Medical, Inc. (NARI) was downgraded to D from D+ on 11/14/2022 due to a decline in the efficiency index and volatility index.
Inari Medical, Inc. (NARI) was downgraded to D from D+ on 11/14/2022 due to a decline in the efficiency index and volatility index.
D
Sell
10/7/2022Upgraded
Inari Medical, Inc. (NARI) was upgraded to D+ from D on 10/7/2022 due to an increase in the volatility index and total return index.
Inari Medical, Inc. (NARI) was upgraded to D+ from D on 10/7/2022 due to an increase in the volatility index and total return index.
D
Sell
9/22/2022Downgrade
Inari Medical, Inc. (NARI) was downgraded to D from D+ on 9/22/2022 due to a decline in the volatility index.
Inari Medical, Inc. (NARI) was downgraded to D from D+ on 9/22/2022 due to a decline in the volatility index.
D
Sell
9/7/2022Upgraded
Inari Medical, Inc. (NARI) was upgraded to D+ from D on 9/7/2022 due to an increase in the total return index and volatility index.
Inari Medical, Inc. (NARI) was upgraded to D+ from D on 9/7/2022 due to an increase in the total return index and volatility index.
D
Sell
7/15/2022Downgrade
Inari Medical, Inc. (NARI) was downgraded to D from D+ on 7/15/2022 due to a decline in the total return index and volatility index.
Inari Medical, Inc. (NARI) was downgraded to D from D+ on 7/15/2022 due to a decline in the total return index and volatility index.
D
Sell
5/6/2022Downgrade
Inari Medical, Inc. (NARI) was downgraded to D+ from C on 5/6/2022 due to a significant decline in the growth index and efficiency index. Earnings per share declined from $0.0202 to -$0.0614, net income declined 382.66% from $1.11M to -$3.13M, and EBIT declined 243.62% from $2.15M to -$3.08M.
Inari Medical, Inc. (NARI) was downgraded to D+ from C on 5/6/2022 due to a significant decline in the growth index and efficiency index. Earnings per share declined from $0.0202 to -$0.0614, net income declined 382.66% from $1.11M to -$3.13M, and EBIT declined 243.62% from $2.15M to -$3.08M.
C
Hold
4/18/2022Upgraded
Inari Medical, Inc. (NARI) was upgraded to C from D+ on 4/18/2022 due to a significant increase in the growth index and efficiency index. Operating cash flow increased 368.51% from -$5.59M to $15.01M, net income increased 139.48% from -$2.8M to $1.11M, and earnings per share increased from -$0.06 to $0.0202.
Inari Medical, Inc. (NARI) was upgraded to C from D+ on 4/18/2022 due to a significant increase in the growth index and efficiency index. Operating cash flow increased 368.51% from -$5.59M to $15.01M, net income increased 139.48% from -$2.8M to $1.11M, and earnings per share increased from -$0.06 to $0.0202.
D
Sell
11/15/2021Downgrade
Inari Medical, Inc. (NARI) was downgraded to D+ from C on 11/15/2021 due to a significant decline in the growth index and efficiency index. Earnings per share declined from $0.07 to -$0.06, operating cash flow declined 176.54% from $7.3M to -$5.59M, and net income declined 168.93% from $4.07M to -$2.8M.
Inari Medical, Inc. (NARI) was downgraded to D+ from C on 11/15/2021 due to a significant decline in the growth index and efficiency index. Earnings per share declined from $0.07 to -$0.06, operating cash flow declined 176.54% from $7.3M to -$5.59M, and net income declined 168.93% from $4.07M to -$2.8M.
C
Hold
11/3/2021Upgraded
Inari Medical, Inc. (NARI) was upgraded to C from C- on 11/3/2021 due to an increase in the total return index and growth index.
Inari Medical, Inc. (NARI) was upgraded to C from C- on 11/3/2021 due to an increase in the total return index and growth index.
C
Hold
10/1/2021Downgrade
Inari Medical, Inc. (NARI) was downgraded to C- from C on 10/1/2021 due to a decline in the volatility index, total return index and valuation index.
Inari Medical, Inc. (NARI) was downgraded to C- from C on 10/1/2021 due to a decline in the volatility index, total return index and valuation index.
C
Hold
8/26/2021Upgraded
Inari Medical, Inc. (NARI) was upgraded to C from C- on 8/26/2021 due to an increase in the total return index, volatility index and valuation index.
Inari Medical, Inc. (NARI) was upgraded to C from C- on 8/26/2021 due to an increase in the total return index, volatility index and valuation index.
C
Hold
8/11/2021Downgrade
Inari Medical, Inc. (NARI) was downgraded to C- from C on 8/11/2021 due to a substantial decline in the volatility index and total return index.
Inari Medical, Inc. (NARI) was downgraded to C- from C on 8/11/2021 due to a substantial decline in the volatility index and total return index.
C
Hold
3/11/2021Upgraded
Inari Medical, Inc. (NARI) was upgraded to C from C- on 3/11/2021 due to a major increase in the growth index, total return index and efficiency index. Total revenue increased 25.56% from $38.72M to $48.61M, net income increased 7.53% from $6.5M to $6.99M, and earnings per share increased from $0.12 to $0.1255.
Inari Medical, Inc. (NARI) was upgraded to C from C- on 3/11/2021 due to a major increase in the growth index, total return index and efficiency index. Total revenue increased 25.56% from $38.72M to $48.61M, net income increased 7.53% from $6.5M to $6.99M, and earnings per share increased from $0.12 to $0.1255.
C
Hold
11/16/2020Upgraded
Inari Medical, Inc. (NARI) was upgraded to C- from D on 11/16/2020 due to a significant increase in the growth index, total return index and solvency index. EBIT increased 1,292.37% from -$603 to $7.19M, operating cash flow increased 574.46% from -$1.13M to $5.34M, and earnings per share increased from -$0.16 to $0.12.
Inari Medical, Inc. (NARI) was upgraded to C- from D on 11/16/2020 due to a significant increase in the growth index, total return index and solvency index. EBIT increased 1,292.37% from -$603 to $7.19M, operating cash flow increased 574.46% from -$1.13M to $5.34M, and earnings per share increased from -$0.16 to $0.12.
D
Sell
8/17/2020None
Inari Medical, Inc. (NARI) was downgraded to D from U on 08/17/2020.
Inari Medical, Inc. (NARI) was downgraded to D from U on 08/17/2020.
